Rhenman & Partners Asset Management AB BMY Holdings History
Rhenman & Partners Asset Management AB's Bristol-Myers Squibb Co Holding Summary
As of 2025-03-31, Rhenman & Partners Asset Management AB held 325,000.00 shares of Bristol-Myers Squibb Co(BMY), totaling $19.82 Mil. This investment constitutes 2.28% of their stock portfolio, and Rhenman & Partners Asset Management AB now holds 0.02% of the outstanding Bristol-Myers Squibb Co(BMY) stock.
The initial trade took place in 2014Q1. And since then Rhenman & Partners Asset Management AB has made 13 purchases of BMY, at an average price of $55.38, for a total of 1.10 Mil shares. In addition, there have been 10 sales at an average price of $59.08 for 771,815.00 shares. Based on historical transaction data and BMY's current price of $47.36, Rhenman & Partners Asset Management AB's estimated gain on his BMY holdings is $245,199.49, reflecting a 0.40% gain to date.
Rhenman & Partners Asset Management AB BMY ($47.36) Holding Chart
Rhenman & Partners Asset Management AB BMY ($47.36) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1